A phase Ib study for MNRP1685A (anti-NRP1) administered intravenously with bevacizumab with or without paclitaxel to patients with advanced solid tumors.
C. D. Weekes
Honoraria - Genentech
P. LoRusso
Consultant or Advisory Role - Genentech
V. Ramakrishnan
Employment or Leadership Position - Roche
Stock Ownership - Roche
L. M. Shih
Employment or Leadership Position - Roche
Stock Ownership - Roche
W. C. Darbonne
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
P. Hegde
Employment or Leadership Position - Roche
Stock Ownership - Roche
Y. Xin
Employment or Leadership Position - Roche
Stock Ownership - Roche
R. Yu
Employment or Leadership Position - Roche
Stock Ownership - Roche
H. Xiang
Employment or Leadership Position - Roche
Stock Ownership - Roche
R. K. Brachmann
Employment or Leadership Position - Roche
Stock Ownership - Roche
A. Patnaik
Honoraria - Roche